Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biased usage of T cell receptor β-chain variable region genes of Wilms' tumor gene (WT1)-specific CD8+ T cells in patients with solid tumors and healthy donors.
Morimoto S, Oka Y, Tsuboi A, Tanaka Y, Fujiki F, Nakajima H, Hosen N, Nishida S, Nakata J, Nakae Y, Maruno M, Myoui A, Enomoto T, Izumoto S, Sekimoto M, Kagawa N, Hashimoto N, Yoshimine T, Oji Y, Kumanogoh A, Sugiyama H. Morimoto S, et al. Among authors: enomoto t. Cancer Sci. 2012 Mar;103(3):408-14. doi: 10.1111/j.1349-7006.2011.02163.x. Epub 2012 Jan 17. Cancer Sci. 2012. PMID: 22126448 Free PMC article.
Alteration of p16 and p15 genes in common epithelial ovarian tumors.
Fujita M, Enomoto T, Haba T, Nakashima R, Sasaki M, Yoshino K, Wada H, Buzard GS, Matsuzaki N, Wakasa K, Murata Y. Fujita M, et al. Among authors: enomoto t. Int J Cancer. 1997 Apr 22;74(2):148-55. doi: 10.1002/(sici)1097-0215(19970422)74:2<148::aid-ijc2>3.0.co;2-z. Int J Cancer. 1997. PMID: 9133447
Wilms' tumor 1 (WT1) peptide immunotherapy for gynecological malignancy.
Ohno S, Kyo S, Myojo S, Dohi S, Ishizaki J, Miyamoto K, Morita S, Sakamoto J, Enomoto T, Kimura T, Oka Y, Tsuboi A, Sugiyama H, Inoue M. Ohno S, et al. Among authors: enomoto t. Anticancer Res. 2009 Nov;29(11):4779-84. Anticancer Res. 2009. PMID: 20032435 Free article. Clinical Trial.
High frequencies of less differentiated and more proliferative WT1-specific CD8+ T cells in bone marrow in tumor-bearing patients: an important role of bone marrow as a secondary lymphoid organ.
Murao A, Oka Y, Tsuboi A, Elisseeva OA, Tanaka-Harada Y, Fujiki F, Nakajima H, Nishida S, Hosen N, Shirakata T, Hashimoto N, Myoui A, Ueda T, Takeda Y, Osaki T, Enomoto T, Yoshikawa H, Kimura T, Oji Y, Kawase I, Sugiyama H. Murao A, et al. Among authors: enomoto t. Cancer Sci. 2010 Apr;101(4):848-54. doi: 10.1111/j.1349-7006.2009.01468.x. Epub 2009 Dec 11. Cancer Sci. 2010. PMID: 20136847 Free PMC article.
WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial.
Miyatake T, Ueda Y, Morimoto A, Enomoto T, Nishida S, Shirakata T, Oka Y, Tsuboi A, Oji Y, Hosen N, Nakatsuka S, Morita S, Sakamoto J, Sugiyama H, Kimura T. Miyatake T, et al. Among authors: enomoto t. J Cancer Res Clin Oncol. 2013 Mar;139(3):457-63. doi: 10.1007/s00432-012-1348-2. Epub 2012 Nov 18. J Cancer Res Clin Oncol. 2013. PMID: 23160854 Clinical Trial.
CpG oligodeoxynucleotides potentiate the antitumor activity of anti-BST2 antibody.
Hiramatsu K, Serada S, Kobiyama K, Nakagawa S, Morimoto A, Matsuzaki S, Ueda Y, Fujimoto M, Yoshino K, Ishii KJ, Enomoto T, Kimura T, Naka T. Hiramatsu K, et al. Among authors: enomoto t. Cancer Sci. 2015 Oct;106(10):1474-8. doi: 10.1111/cas.12738. Cancer Sci. 2015. PMID: 26498112 Free PMC article.
1,407 results